FFCP PHASE1:Hg19::chr6:160351875..160351879,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=not supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C1218 | |||
|description=CAGE_peak_at_chr6:160351875..160351879,- | |||
|id=chr6:160351875..160351879,- | |||
|ontology_enrichment_celltype=CL:0000945!3.29e-23!24;CL:0000826!3.29e-23!24;CL:0000838!2.94e-21!52;CL:0000542!8.24e-21!53;CL:0000051!8.24e-21!53;CL:0000946!6.03e-09!1;CL:0000786!6.03e-09!1;CL:0000980!6.03e-09!1;CL:0000988!3.18e-08!182;CL:0002087!7.71e-08!119;CL:0000738!1.75e-07!140;CL:0002031!1.98e-07!124 | |||
|ontology_enrichment_celltype_v019=CL:0000946;1.88e-50;1!CL:0000786;1.88e-50;1!CL:0000945;2.56e-09;24!CL:0000542;4.11e-09;53!CL:0000084;5.49e-09;25 | |||
|ontology_enrichment_celltype_v019_2=CL:0000946,2.42e-50,1;CL:0000786,2.42e-50,1;CL:0000980,2.42e-50,1;CL:0000785,5.56e-26,2;CL:0000955,5.56e-26,2;CL:0000818,5.56e-26,2;CL:0000954,5.56e-26,2;CL:0000816,5.56e-26,2;CL:0000817,8.00e-18,3;CL:0000838,4.67e-16,52;CL:0000542,9.01e-16,53;CL:0000051,9.01e-16,53;CL:0000945,2.67e-09,24;CL:0000826,2.67e-09,24;CL:0000084,5.27e-09,25;CL:0000827,5.27e-09,25;CL:0002087,1.17e-07,115;CL:0002031,2.26e-07,120 | |||
|ontology_enrichment_development_v019=CL:0000954;4.90e-26;2!CL:0000051;4.11e-09;53 | |||
|ontology_enrichment_disease=DOID:0060058!6.00e-26!10;DOID:2531!3.11e-10!51;DOID:0060083!3.11e-10!51;DOID:0060060!6.50e-09!1;DOID:0060061!6.50e-09!1;DOID:8691!6.50e-09!1;DOID:2355!7.01e-09!1;DOID:630!1.48e-08!1;DOID:0050177!1.48e-08!1;DOID:0050427!1.48e-08!1;DOID:4960!1.71e-08!1;DOID:0070004!1.71e-08!1 | |||
|ontology_enrichment_disease_v019=DOID:0060060;5.12e-50;1!DOID:0060061;5.12e-50;1!DOID:8691;5.12e-50;1!DOID:2355;5.12e-50;1!DOID:74;8.10e-26;2!DOID:0060058;1.04e-20;10!DOID:1287;1.21e-13;4!DOID:2531;4.43e-07;51!DOID:0060083;4.43e-07;51 | |||
|ontology_enrichment_disease_v019_2=DOID:0060060,3.99e-50,1;DOID:0060061,3.99e-50,1;DOID:8691,3.99e-50,1;DOID:2355,6.58e-50,1;DOID:74,9.18e-26,2;DOID:0060058,1.04e-20,10;DOID:1287,1.29e-13,4;DOID:2531,1.24e-09,51;DOID:0060083,1.24e-09,51 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.382067028739756,0,0.0787107813136792,0,0,0,0,0,0,0,0.568676929949686,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164437904603676,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.571994910780128,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.121973706129595,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.111443384277478,0,0,0,0,0,0,0,0.494411622680279,0,0,0,0,0,0.861593638227486,0,0.0898683511473268,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139423744278603,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.37950746544837,0,0,0.163232808159148,0,0,0,0,0,0.593042257361244,0.247127877893006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.137041924646751,0,0,0,0.0801588202515337,0,0,0,0,0,0.14405479798815,0,0,0,0,0,0,0,0,0,0,3.6804229599104,0,0,0,0,0,0,0,0,0,0,0,0,0,1.1007533168552,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.852548188666271,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.107410557042488,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.39991177098451,0,0.172214979660816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.57225361422916,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.347716544605159,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.112131862580613,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.320568492303233 | |||
|short_description=p@chr6:160351875..160351879,- | |||
}} |
Revision as of 15:00, 22 January 2014
Short description: | p@chr6:160351875..160351879, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | No |
Description: | CAGE_peak_at_chr6:160351875..160351879, - |
Coexpression cluster: | C1218_hairy_plasma_lymphoma_xeroderma_hereditary_mycosis_splenic |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
antibody secreting cell | 2.42e-50 | 1 |
plasma cell | 2.42e-50 | 1 |
plasmablast | 2.42e-50 | 1 |
mature B cell | 5.56e-26 | 2 |
pre-B-II cell | 5.56e-26 | 2 |
transitional stage B cell | 5.56e-26 | 2 |
small pre-B-II cell | 5.56e-26 | 2 |
immature B cell | 5.56e-26 | 2 |
precursor B cell | 8.00e-18 | 3 |
lymphoid lineage restricted progenitor cell | 4.67e-16 | 52 |
lymphocyte | 9.01e-16 | 53 |
common lymphoid progenitor | 9.01e-16 | 53 |
lymphocyte of B lineage | 2.67e-09 | 24 |
pro-B cell | 2.67e-09 | 24 |
T cell | 5.27e-09 | 25 |
pro-T cell | 5.27e-09 | 25 |
nongranular leukocyte | 1.17e-07 | 115 |
hematopoietic lineage restricted progenitor cell | 2.26e-07 | 120 |
Ontology term | p-value | n |
---|---|---|
non-Hodgkin lymphoma | 3.99e-50 | 1 |
cutaneous T cell lymphoma | 3.99e-50 | 1 |
mycosis fungoides | 3.99e-50 | 1 |
anemia | 6.58e-50 | 1 |
hematopoietic system disease | 9.18e-26 | 2 |
lymphoma | 1.04e-20 | 10 |
cardiovascular system disease | 1.29e-13 | 4 |
hematologic cancer | 1.24e-09 | 51 |
immune system cancer | 1.24e-09 | 51 |